Irfan Khan provides personalized insights into these medications, helping patients choose the right GLP-1 option for their weight loss journey
No specific clinical result is promised or guaranteed
In pooled Zepbound weight-reduction trials, nausea was reported in 25% to 29% of treatment groups across labeled doses compared with 8% receiving placebo
Effect of pemvidutide, a GLP-1/glucagon dual receptor agonist, on MASLD: a randomized, double-blind, placebo-controlled study
Remedies such as ginger tea and mint tea are also helpful in relieving nausea
In addition, combining GLP-1RAs with other therapeutic agents, such as sodium-glucose cotransporter 2 inhibitors (SGLT2i), has shown synergistic effects in reducing liver stiffness and improving overall liver health (Lin et al., 2024)